It has been a bloody and bitter fight. Merck’s (MRK) pain killer Vioxx has been alleged to cause heart problems and worse. The drug hit the market in 1999 and was pulled…
Douglas A. McIntyre The markets haven’t fallen apart after yesterday’s 360 point dive on the DJIA, but we are still trading a tad lower today. Now that Cisco Systems is showing you can’t just automatically…
GTx, Inc. (NASDAQ: GTXI) is seeing shares trade sharply higher on a collaboration pact with Merck (NYSE: MRK). The biotech and drug giant pact is for research and development and a strategic…
Douglas A. McIntyre With the markets down so much today on the financial stock fallout after the Citi downgrade/concern and with oil stocks listing lower after the Exxon miss, we wanted to show a brief…
Merck (MRK) announced third-quarter 2007 earnings per share of $0.75, excluding restructuring charges, and third-quarter reported EPS of $0.70. Worldwide sales were $6.1 billion for the quarter, an increase of 12 percent…
Douglas A. McIntyre Astoday is the 20th anniversary of the 1987 stock market crash, 24/7 WallSt. wanted to go back in time to review how the individual DJIAcomponents held up around the time and how…
Merck’s (MRK) has won almost every liability case it has faced over side-effects of its pain killer Vioxx. It has gotten to the point where plaintiff’s attorneys don’t want to risk their…
Douglas A. McIntyre According to Reuters, Nokia (NOK) said the the ITC has begin an investigation into Qualcomm (QCOM) trade practives and patent infringements. Reuters writes that Boeing (BA) is estimating that China will need…
We are frequently asked about how certain basket picks perform compared to the overall market. It has been years since anyone has claimed their stocks should gain regardless of the market because…
If you ever heard the old saying "Be careful what you wish for, you may get it!" it sure seems like we are there. It also makes you wonder if it is…
Patients who swtich from Pfizer’s (PFE) monster selling drug cholesterol pill Lipitor to Merck’s (MRK) Zocor, now available in generic form are more likely to have a heart attack or die. According…
Business Week has run a brief feature article on Ariad Pharmaceuticals (NASDAQ:ARIA) in its "Inside Wall Street" magazine section and noted that the company’s partner Merck (NYSE:MRK), has "deep pockets." Unfortunately it…
Douglas A. McIntyre A new medical study shows that people who take statins, cholesterol-lowering drugs, appear to be less likely to develope Alzheimer’s, one of the most damaging and fastest growing diseases. Pfizer’s (PFE) Lipitor…
Last Friday, we wrote about defensive stock havens for a crummy stock market. We also warned that in true market selling extremes there is no such thing as a true haven, and…
It’s yet another crummy day in the markets with roughly a 280 DJIA point drop before the closing bell went off. Bear Stearns added the most fuel at the end of the…